uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Levels of cytokines and GADA in type I and II diabetic patients: Levels of cytokines and GADA in type I and II diabetic patients
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences. (Lung- allergi- och sömnforskning, Lung- allergy- and sleep research)
2019 (English)In: Primary Care Diabetes, ISSN 1751-9918, E-ISSN 1878-0210Article in journal, News item (Other (popular science, discussion, etc.)) In press
Abstract [en]

AbstractBACKGROUND:

Diabetes Mellitus is described as a group of metabolic diseases in which the patient has higher blood glucose levels due to many causes. These include a defect in insulin secretion and failure of the body's cells to respond to the hormone. Cytokines and autoantibodies have a critical role in the pathogenesis of diabetes, especially type I.

AIM OF THE STUDY:

The aim of this study was to measure the serum levels of interleukin-1 beta (IL-1 β), interleukin-3 (IL-3), interferon-gamma (INF- γ), and glutamic acid decarboxylase autoantibody (GADA) in patients with type I and type II diabetes mellitus.

MATERIAL AND METHODS:

In this cross-sectional study, serum samples were taken from 250 individuals, including 100 samples from patients with type II diabetes mellitus, 100 samples from healthy controls, and 50 samples from patients with type I diabetes mellitus. Five milliliters of venous blood were taken from each individual and the samples were analyzed for cytokines (IL-1 β, IL-3, and INF- γ) and GABA using ELISA.

RESULTS:

In the study, we found that the serum levels of IL-1 β were significantly higher in the healthy control group compared to the patients with type I and type II diabetes mellitus. The levels of IL-3 and INF- γ were significantly higher in type II diabetes mellitus, while GABA serum levels were higher in type I diabetes mellitus.

CONCLUSION:

Our data showed that GADA is an important autoantibody, not only in type I but also in type II diabetes mellitus and can probably be used in the future for diagnosis of this disease. There was also a close association of GADA with systemic immunoregulation in type I and II diabetes mellitus. The relation of cytokines (IL-1 β, IL-3, and INF- γ) and GADA in patients with diabetes will also increase our understanding for the immunology of diabetes mellitus and to propose specific treatment on the basis of our findings. Our data also include correlation between age and the level of cytokines and GADA with different conclusion for each parameter.

Place, publisher, year, edition, pages
Radarweg 29, 1043 NX Amsterdam, The Netherlands, 2019.
Keywords [en]
GADA; IFN-γ; IL-1β; IL-3; Immune system
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-383252DOI: 10.1016/j.pcd.2019.03.008OAI: oai:DiVA.org:uu-383252DiVA, id: diva2:1315125
Available from: 2019-05-11 Created: 2019-05-11 Last updated: 2019-05-11

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text
By organisation
Department of Medical Sciences
In the same journal
Primary Care Diabetes
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 8 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf